Istituto Dermopatico dell'Immacolata

本机构学者在这里署名、按本站篇数

合作机构同一篇文章里的其他机构

1. Policlinico Tor Vergata意大利1
2. University of Verona意大利1
3. Università Cattolica del Sacro Cuore意大利1
4. Sapienza University of Rome意大利1
5. University of Naples Federico II意大利1

按月发文

逐年被引

最新文献

1. 1
   Biological therapies in infants and children younger than 6 years of age with atopic dermatitis: suitability and practical considerationsExpert Opinion on Drug Safety20242
2. 2
   Infectious events in patients with alopecia areata treated with JAK inhibitors: low burden and minimal impact on persistence in treatmentExpert Opinion on Drug Safety20244
3. 3
   Dupilumab in real-life settings: a review of adverse events and their pathogenesisExpert Opinion on Drug Safety202429
4. 4
   Efficacy and safety of spesolimab for the management of generalized pustular psoriasis: a drug safety evaluationExpert Opinion on Drug Safety20236

高被引文献

1. 1
   Dupilumab in real-life settings: a review of adverse events and their pathogenesisExpert Opinion on Drug Safety202429
2. 2
   Efficacy and safety of spesolimab for the management of generalized pustular psoriasis: a drug safety evaluationExpert Opinion on Drug Safety20236
3. 3
   Infectious events in patients with alopecia areata treated with JAK inhibitors: low burden and minimal impact on persistence in treatmentExpert Opinion on Drug Safety20244
4. 4
   Biological therapies in infants and children younger than 6 years of age with atopic dermatitis: suitability and practical considerationsExpert Opinion on Drug Safety20242

主要发表期刊